CytomX Therapeutics, Inc. (FRA:6C1)
Germany · Delayed Price · Currency is EUR 3.604
+0.032 (0.90%)
At close: Dec 1, 2025
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of €625.26 million as of December 2, 2025. Its market cap has increased by 736.56% in one year.
Market Cap
625.26M
Enterprise Value
506.53M
Revenue
96.85M
Ranking
n/a
PE Ratio
26.18
Stock Price
€3.60
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from 399.33M to 625.26M, an increase of 56.58%. That is a compound annual growth rate of 4.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 625.26M | 703.08% |
| Dec 31, 2024 | 77.86M | -17.12% |
| Dec 29, 2023 | 93.94M | -5.05% |
| Dec 30, 2022 | 98.94M | -60.18% |
| Dec 31, 2021 | 248.43M | 0.37% |
| Dec 31, 2020 | 247.51M | -26.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |